U.S. Department of Health and Human Services
Sheryl Sato

 Contact Info

Tel: 301-594-8811
Email: smsato@mail.nih.gov

 Select Experience

  • Program DirectorNINDS, NIH1998
  • Senior Staff FellowNIDDK, NIH1989-1998
  • Senior Staff FellowNICHD, NIH1987-1989
  • Postdoctoral TrainingThe Johns Hopkins University1983-1987
  • Ph.D.The Johns Hopkins University1983

Current Responsibilities & Activities

My responsibilities include managing research programs in developmental biology, stem cell biology and the regeneration of endocrine tissue and organs.  I direct a program in islet biology that supports mechanistic studies to understand integrated islet function, beta cell renewal, and pathophysiology.

In addition, I help to coordinate research in the Human Islet Research Network (HIRN), a basic science research effort which is developing innovative strategies for the treatment, prevention and monitoring of type 1 diabetes.   Within HIRN,  I serve as the project scientist for the Consortium on Human Islet Biomimetics (CHIB), and am the program officer for the Consortium on Targeting and Regeneration (CTAR), and the Consortium on Beta Cell Death and Survival (CBDS).  In addition, I serve as the program officer for the Integrated Islet Distribution Program.

In addition to my duties in the Division of Diabetes, Endocrinology, and Metabolic Diseases, I also participate in NIDDK working groups that focus on genetics and genomics, obesity, stem cells, and type 1 diabetes.

​Research Programs

Bioengineering, Biotechnology, and Imaging as applied to Diabetes, Metabolic, and Endocrine Diseases
This program supports research that is aimed at applying sophisticated, cutting-edge technologies to advance the understanding of the mechanisms that underlie diabetes and other endocrine and metabolic diseases

Endocrine Pancreas
The Endocrine Pancreas program supports research on the basic biology, development, and function of the endocrine pancreas as well as clinical studies on islet transplantation for the treatment of type 1 diabetes

Genetic Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology and treatment of inborn errors of metabolism and rare genetic metabolic diseases, including lipodystrophy, maturity onset diabetes of the young (MODY), Primary Hyperoxaluria, systemic amyloidosis and porphyria.

Current Committee Memberships

  • NIDDK Genetics & Genomics Working GroupMember
  • NIDDK Obesity Research Working GroupMember
  • NIDDK Type 1 Diabetes Working GroupMember